Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Do Wound Protectors Reduce Contamination in Total Shoulder Arthroplasty?

NCT: NCT06513182 · COMPLETED

NCT IDNCT06513182
StatusCOMPLETED
Start Date2024-06-21
Completion2026-03-12
SponsorUniversity of Utah (OTHER)
First posted
Last updated

Brief Summary

Prosthetic joint infection is a devastating complication of shoulder arthroplasty. A relatively novel method of preventing PJI has been with the use of a wound protection device. There is minimal investigative research on the use of a wound protector in shoulder arthroplasty, specifically with an ability to decrease wound contamination. The investigators primary purpose of the proposed study is to determine if the use of a wound protector deceases the deep wound colonization of bacteria in primary shoulder arthroplasty. A secondary purpose is to evaluate if the wound protector decreases soft tissue trauma during total shoulder arthroplasty.

Frequently Asked Questions

What is Do Wound Protectors Reduce Contamination in Total Shoulder Arthroplasty??

Do Wound Protectors Reduce Contamination in Total Shoulder Arthroplasty? is a clinical trial registered under NCT06513182. Current status: COMPLETED.

What is the status of NCT06513182?

The current status of NCT06513182 (Do Wound Protectors Reduce Contamination in Total Shoulder Arthroplasty?) is: COMPLETED.

When did Do Wound Protectors Reduce Contamination in Total Shoulder Arthroplasty? start?

Do Wound Protectors Reduce Contamination in Total Shoulder Arthroplasty? started on 2024-06-21.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.